Literature DB >> 24303604

The efficacy and safety of a pharmacologic protocol for maintaining coronary artery bypass patients at a higher mean arterial pressure during cardiopulmonary bypass. 1998.

P A Pirraglia1, J C Peterson, G S Hartman, F S Yao, S J Thomas, M E Charlson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24303604      PMCID： PMC4393745     

Source DB:  PubMed          Journal:  J Extra Corpor Technol        ISSN： 0022-1058


× No keyword cloud information.
  30 in total

1.  Myocardial metabolism during anaesthesia with propofol--low dose fentanyl for coronary artery bypass surgery.

Authors:  K M Vermeyen; S G De Hert; F A Erpels; H F Adriaensen
Journal:  Br J Anaesth       Date:  1991-04       Impact factor: 9.166

2.  Coronary artery bypass operation in dialysis patients.

Authors:  T D Batiuk; S B Kurtz; J K Oh; T A Orszulak
Journal:  Mayo Clin Proc       Date:  1991-01       Impact factor: 7.616

3.  Surgical bleeding: unexpected effect of a calcium antagonist.

Authors:  L E Wagenknecht; C D Furberg; J W Hammon; C Legault; B T Troost
Journal:  BMJ       Date:  1995-03-25

4.  Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: a multivariate analysis in cardiac surgical patients.

Authors:  G J Despotis; K S Filos; T N Zoys; C W Hogue; E Spitznagel; D G Lappas
Journal:  Anesth Analg       Date:  1996-01       Impact factor: 5.108

5.  Improvement of outcomes after coronary artery bypass. A randomized trial comparing intraoperative high versus low mean arterial pressure.

Authors:  J P Gold; M E Charlson; P Williams-Russo; T P Szatrowski; J C Peterson; P A Pirraglia; G S Hartman; F S Yao; J P Hollenberg; D Barbut
Journal:  J Thorac Cardiovasc Surg       Date:  1995-11       Impact factor: 5.209

6.  Acute renal failure in the patient undergoing cardiac operation. Prevalence, mortality rate, and main risk factors.

Authors:  G Zanardo; P Michielon; A Paccagnella; P Rosi; M Caló; V Salandin; A Da Ros; F Michieletto; G Simini
Journal:  J Thorac Cardiovasc Surg       Date:  1994-06       Impact factor: 5.209

7.  Heparin management protocol for cardiopulmonary bypass influences postoperative heparin rebound but not bleeding.

Authors:  G P Gravlee; A T Rogers; L M Dudas; R Taylor; R C Roy; L D Case; M Triscott; C W Brown; L J Mark; A R Cordell
Journal:  Anesthesiology       Date:  1992-03       Impact factor: 7.892

8.  Comparative vascular effects of midazolam and lorazepam administered during cardiopulmonary bypass.

Authors:  S E McNulty; D Gratch; J Y Kim
Journal:  Anesth Analg       Date:  1994-10       Impact factor: 5.108

9.  Heparin rebound: a comparative study of protamine chloride and protamine sulfate in patients undergoing coronary artery bypass surgery.

Authors:  A H Kuitunen; M T Salmenperä; J Heinonen; V P Rasi; G Myllylä
Journal:  J Cardiothorac Vasc Anesth       Date:  1991-06       Impact factor: 2.628

10.  The effects of anesthetic technique on the hemodynamic response and recovery profile in coronary revascularization patients.

Authors:  C T Mora; C Dudek; M C Torjman; P F White
Journal:  Anesth Analg       Date:  1995-11       Impact factor: 5.108
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.